Ovixan
PACKAGE LEAFLET
PACKAGE LEAFLET: INFORMATION FOR THE USER
Ovixan 1 mg/g cutaneous solution
Mometasone furoate
-
Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
-
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet please tell your doctor or pharmacist. See section 4.
In this leaflet:
1. What Ovixan is and what it is used for
2. Before you use Ovixan
3. How to use Ovixan
4. Possible side effects
How to store Ovixan
6. Further information
What Ovixan is and what is is used for
Ovixan contains the active substance mometasone furoate and it is a corticosteroid for cutaneous use. Corticosteroids for cutaneous use are divided into four classes depending on strength and effect: mild effect, medium effect, strong effect and very strong effect. Mometasone furoate belongs to the class “corticosteroid with strong effect”.
Adults and children above 6 years:
Ovixan has an anti-inflammatory effect and reduces itchiness. Ovixan is used to decrease symptoms in connection with inflammatory skin conditions that can be treated with a corticosteroid, e. g. psoriasis (excluding widespread plaque psoriasis) and some types of dermatitis. It does not cure your skin disease, but it relieves your symptoms.
What you need to know before you use Ovixan
Do not use Ovixan
-
if you are allergic to mometasone furoate, other corticosteroids or any of the other ingredients of this medicine (listed in section 6).
-
for other skin diseases that may become worse, especially rosacea (skin disease in the face), acne, rash around the mouth (dermatitis), skin atrophy, itching in the genitals and around the anus, napkin eczema, bacterial infections such as impetigo, tuberculosis (lung disease), syphilis (sexually contageous disease), viral infections such as mouth sores, shingles, chicken pox, athlete’s foot (red, itching, scaling skin on your feet), or Candida infection in the genitals that may cause secretion and itching or other skin diseases.
-
if you have recently experienced adverse events after a vaccination (e. g. against influenza)
-
on wounds or on ulcerated skin
Warnings and precautions
-
Inform your doctor if you are pregnant, suspect that you are pregnant, or if you are breastfeeding.
-
Inform your doctor at once if you experience irritation or hypersensitivity when using Ovixan.
-
As for all strong corticosteroids for topical use, treatment should not be stopped suddenly. If long term treatment is stopped relapse in the form of skin infections with intense redness, stinging and burning may occur. This can be prevented by decreasing the treatment gradually e.g. by applying the cream less frequently before stopping the treatment.
-
Treatment of psoriasis with this medication may result in skin problems becoming worse (e.g. a pustular form of this disease with many small ulcers on your skin may appear). Your doctor must supervise the development of your problems regularly, since this type of treatment requires careful supervision.
-
Ovison should not be used on damaged skin.
-
Do not use the solution on your eyelids. Be careful and avoid getting solution in your eyes.
Other medicines and Ovixan
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, and other cures or dietary supplements such as vitamins. Consult your doctor before using other medicines.
Pregnancy, breast-feeding and fertility
It you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Treatment with Ovixan during pregnancy or breast-feeding may only be started after instructions from your doctor.
If your doctor prescribes use of the solution during pregnancy or breast-feeding you must avoid using large quantities and you must only use the solution during a short period of time. Ovixan should not be applied on the breast or on adjacent skin during breast-feeding.
Ovixan contains propylene glycol
Ovixan contains propylene glycol that may cause skin irritation.
How to use Ovixan
Ovixan is intended for cutaneous (external) use. Ovixan may only be used on the skin.
-
Always use Ovixan exactly as your doctor has told you. You should check with your doctor or pharmacist if you are unsure.
-
Your doctor should supervise your treatment regularly.
-
Do not use the solution in your face without prescription by your doctor
-
Avoid getting solution in your eyes.
-
You should not cover the treated area with a compress or bandage if your doctor has not instructed you to do so. This is to decrease the risk of adverse events.
Dosage:
Carefully apply a thin layer of solution on the affected skin once daily. You should only use a small amount of the solution.The bottle has a dropper that makes it easier to apply the solution. Never use a larger amount, and do not use it more often than advised by your doctor or pharmacist.
Adults, including older people:
Do not use the solution on large areas (more that 20 % of the skin surface) or for a long period of time.
Use in children (6 years of age and over):
-
Do not use the solution in children above 6 years without prescription by your doctor.
-
Do not use the solution on more that 10 % of the childs skin surface.
Children below 6 years:
Ovixan is not recommended for children below 6 years.
If you use more Ovixan than you should
If you swallow the solution by mistake this should not lead to any adverse effects.
If you have not followed your doctors instructions and you have used the solution too often and/or during a long period you should ask your doctor or pharmacist for advice.
If you forget to use Ovixan
If you forget to apply the solution at the time when you should, do it as soon as you remember and then continue as before. Do not use the double amount and do not apply the solution twice in a day to compensate for a forgotten treatment.
If you stop using Ovixan
Do not stop treatment suddenly if you have used the solution for a long time since this can be harmful. The treatment should be gradually decreased according to your doctors instructions.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects in children and adults that have been reported during use of corticosteroids for cutaneous use include:
Very rare (may affect up to 1 in 10,000 people):
-Inflammation of the hair follicles
-Itching
-Increased superficial blood vessels or spider vains
-Burning sensation
Not known (frequency cannot be estimated from the available data)
-Pain or other reactions at the application site
-Secondary infections (an infection that appears during or after treatment of another infection or disease)
-Ulcers in the face
-Paresthesia (abnormal or numbing sensation on the skin)
-Changes in skin colour
-Skin maceration (softening and bleaching of the skin)
-Miliaria (heat rashes, very itchy rashes)
-Inflammation (including acne like reactions)
-Skin thinning
-Irregular spots or lines on the skin
-Abnormal growth of hair
-Increased sensitivity
-Dryness
Increased use, treatment of larger skin surfaces, longterm use and treatment with occlusion may increase the risk for side effects.
Corticosteroids may affect the normal hormone production of the body. This is more likely during use of high doses during a longer time period.
Additional side effects in children
In particular children that are treated with corticosteroid solutions, creams and ointments may absorb the product through the skin, which can lead to a disease called Cushing’s syndrome. This syndrome has many symptoms, among these development of a rounder face and weakness.
Growth in children may be inhibited during longterm use. Your doctor will prevent this risk by prescribing the lowest possible corticosteroid dose for a controlled treatment of your symptoms.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Ovixan
Keep this medicine out of the sight and reach of children.
Do not use Ovixan after the expiry date which is stated on the bottle and carton after Exp. The expiry date refers to the last day of that month.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. Contents of the pack and other information
What Ovixan contains
-
The active substance is mometasone furoate. Each gram of Ovixan cutaneous solution contains 1 mg of mometasone furoate.
-
The other ingredients are: propylene glycol, isopropyl alcohol, hydroxypropylcellulose, sodium dihydrogen phosphate dihydrate, concentrated phosphoric acid (for pH adjustment) and purified water.
Please see section 2“Ovixan contains propylene glycol”.
What Ovixan looks like and contents of the pack
Ovixan 1 mg/g cutaneous solution is a colourless to slightly yellow low-viscous solution filled in white polyethylene bottles with a dropper and a white screwcap of polyethylene.
Pack-sizes: 30 ml, 100 ml and 2x100 ml
Not all pack-sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Galenica AB
P A Hanssons väg 41
SE-203 12 Malmö
Sweden
Manufacturer
Laboratorio Reig Jofré S.A.
Gran Capitán 10
Sant Joan Despí
08970 Barcelona
Spain
This medicinal product is authorised in the Member States of the EEA under the following names:
Country |
Trade names |
Czech Republic |
OVIXAN 1 MG/G kožní roztok |
Denmark |
Ovison 1mg/g Kutanopløsning |
Finland |
Ovixan 1 mg/g Liuos iholle |
Iceland |
Ovixan 1 mg/g Húðlausn |
Italy |
OVISON 1 MG/G SOLUZIONE CUTANEA |
Norway |
Ovixan 0.1% Liniment oppløsning |
Poland |
Ovixan 1 mg/g roztwór na skórę |
Slovenia |
Ovixan 1 mg/g dermalna raztopina |
Sweden |
Ovixan 1 mg/g Kutan lösning |
|
|
This leaflet was last revised in 2015-04-07
5